These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 18378319)

  • 1. Pharmacological approach to the treatment of long and short QT syndromes.
    Patel C; Antzelevitch C
    Pharmacol Ther; 2008 Apr; 118(1):138-51. PubMed ID: 18378319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long and short QT syndrome.
    Borchert B; Lawrenz T; Stellbrink C
    Herzschrittmacherther Elektrophysiol; 2006 Dec; 17(4):205-10. PubMed ID: 17211751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and long QT syndromes: does QT length really matter?
    Couderc JP; Lopes CM
    J Electrocardiol; 2010; 43(5):396-9. PubMed ID: 20728018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis.
    Roden DM; Spooner PM
    J Cardiovasc Electrophysiol; 1999 Dec; 10(12):1664-83. PubMed ID: 10636197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of pharmacotherapy in cardiac ion channelopathies.
    El-Sherif N; Pedalino R; Himel H
    Curr Vasc Pharmacol; 2009 Jul; 7(3):358-66. PubMed ID: 19601860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of pharmacotherapy in cardiac ion channelopathies.
    El-Sherif N; Boutjdir M
    Pharmacol Ther; 2015 Nov; 155():132-42. PubMed ID: 26376080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Electrical Heart Disease-Principles of Pathophysiology and Genetics.
    Badura K; Buławska D; Dąbek B; Witkowska A; Lisińska W; Radzioch E; Skwira S; Młynarska E; Rysz J; Franczyk B
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 10. The genetic basis of long QT and short QT syndromes: a mutation update.
    Hedley PL; Jørgensen P; Schlamowitz S; Wangari R; Moolman-Smook J; Brink PA; Kanters JK; Corfield VA; Christiansen M
    Hum Mutat; 2009 Nov; 30(11):1486-511. PubMed ID: 19862833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical short QT syndrome models: studying the phenotype and drug-screening.
    Fan X; Yang G; Kowitz J; Duru F; Saguner AM; Akin I; Zhou X; El-Battrawy I
    Europace; 2022 Mar; 24(3):481-493. PubMed ID: 34516623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies.
    Tonko JB; Lambiase PD
    Cardiovasc Res; 2024 Mar; 120(2):114-131. PubMed ID: 38195920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short QT Syndromes].
    Schulze-Bahr E
    Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
    ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
    Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome.
    Zhao Z; Zang X; Niu K; Song W; Wang X; Mügge A; Aweimer A; Hamdani N; Zhou X; Zhao Y; Akin I; El-Battrawy I
    EBioMedicine; 2024 May; 103():105108. PubMed ID: 38653189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.
    Witchel HJ; Hancox JC
    Clin Exp Pharmacol Physiol; 2000 Oct; 27(10):753-66. PubMed ID: 11022966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long QT syndrome: ion channel diseases of the heart.
    Ackerman MJ
    Mayo Clin Proc; 1998 Mar; 73(3):250-69. PubMed ID: 9511785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of arrhythmias--a new paradigm.
    Schulze-Bahr E; Haverkamp W; Borggrefe M; Wedekind H; Mönnig G; Mergenthaler J; Assmann G; Funke H; Breithardt G
    Z Kardiol; 2000; 89 Suppl 4():IV12-22. PubMed ID: 10810773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.